Transient decrease in osteocalcin and markers of type 1 collagen turnover during high-dose corticosteroid pulse...

Area of Science:

• Biochemistry
• Rheumatology
• Endocrinology

Background:

• Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting joints.
• Bone metabolism is often altered in patients with active RA.
• Corticosteroids are commonly used to manage RA, but their precise effects on bone metabolism require further elucidation.

Purpose of the Study:

• To investigate the impact of corticosteroid pulse therapy on bone metabolism markers in patients with active RA.
• To assess transient changes in bone formation and resorption following pulse therapy.

Main Methods:

• Studied 10 patients with active RA undergoing corticosteroid pulse therapy.
• Measured serum levels of alkaline phosphatase, osteocalcin, and collagen type 1 markers: procollagen type 1 N-terminal peptide (PICP) for synthesis and C-terminal telopeptide of type 1 collagen (ICTP) for degradation.
• Analyzed marker levels before, immediately after, and three weeks after pulse therapy.

Main Results:

• A statistically significant decrease in osteocalcin, PICP, and ICTP was observed the day after pulse therapy (P < 0.05).
• These bone metabolism markers returned to baseline levels three weeks post-therapy.
• Transient reduction in bone formation (osteocalcin, PICP) and bone resorption (ICTP) occurred during pulse treatment.

Conclusions:

• Corticosteroid pulse therapy induces a temporary decrease in bone formation and resorption in active RA patients.
• The observed changes in ICTP suggest a transient reduction in bone resorption, though the mechanism (direct vs. indirect) remains unclear.
• Further research on ICTP as a serum marker for bone resorption is warranted.